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Abstract
Background: People living with a long term condition may wish to be able to plan ahead, so that if in future they
cannot make decisions, their wishes about their care will be known; this process is termed Advance Care Planning
(ACP). In dementia, guidance stipulates that ACP discussions should take place whilst the person still has capacity
to make decisions. However there is a lack of evidence on the effectiveness of ACP in influencing patient choice
and resource use. The aims of this study are to determine the effectiveness of ACP in dementia care, identify the
factors which facilitate the process in practice and provide a better understanding of the views and experiences of
key stakeholders in order to inform clinical practice.
Methods/Design: The four phase project comprises a systematic review (Phase 1) and a series of qualitative
studies (Phases 2 and 3), with data collection via focus groups and individual interviews with relevant stakeholders
including people with dementia and their carers, health and social care professionals and representatives from
voluntary organisations and the legal profession. The conduct of the systematic review will follow current best
practice guidance. In phases 2 and 3, focus groups will be employed to seek the perspectives of the professionals;
individual interviews will be carried out with people with dementia and their carers. Data from Phases 1, 2 and 3
will be synthesised in a series of team workshops to develop draft guidance and educational tools for
implementing ACP in practice (Phase 4).
Discussion: In the UK, there is little published research on the effectiveness of ACP, despite its introduction into
policy. This study was designed to explore in greater depth how ACP can best be carried out in routine practice. It
affords the opportunity to develop both a theoretical and practical understanding of an area which both patients
and professionals may find emotionally challenging. Importantly the study will also develop practical tools, which
are grounded in practice, for all relevant stakeholders to enable the facilitation of timely and sensitive ACP
discussions.
Background
Life expectancy is increasing by two years every decade.
Currently older people represent the fastest growing sec-
tor of our population, with those over 60 years of age
comprising one fifth of the population. The largest
population increase will be seen in the oldest old i.e.
people over 85 years. An ageing population will
undoubtedly lead to an increased incidence of long term
conditions, especially age-related illness such as osteoar-
thritis and dementia [1].
In the United Kingdom, improving the health and
social care of our ageing population is one of the gov-
ernment’s strategic priority areas [2,3]. However there
i sc l e a re v i d e n c et h a tt h eq u a l i t yo fc a r er e c e i v e db y
some older people is suboptimal, for example people
with advanced dementia experience inappropriate hos-
pital admissions, inadequate symptom management
and a lack of integrated care at the end of life [4,5]. In
addition in terms of patient choice, most older people
would choose to die in their own homes [6,7]; however
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hospice [8].
People living with a long term condition, especially
those with dementia, may wish to be able to plan ahead,
so that if in future they cannot make decisions, their
wishes about their care will be known; this process is
termed Advance Care Planning (ACP). Advance direc-
tives (ADs) or living wills are documents in which an
adult can record preferences for future care. ADs first
appeared in the United States (US) in the 1960s and
became more common after 1990, when the US govern-
ment introduced the Patient Self Determination Act
which requires Medicare and Medicaid providers to
inform patients of their right to complete an advance
directive, at the time of admission. In addition to an
“advance directive or decision” stating informed consent
to refuse specific treatment if loss of mental capacity
ensues, people can nominate others to make decisions
on their behalf, should they lose mental capacity, in the
areas of finance and/or health and personal welfare
(Lasting Power of Attorney). The legal framework
regarding loss of capacity/competency can vary between
countries, and in the US, between states.
In terms of the processes that facilitate AD comple-
tion rate, systematic reviews have concluded that multi-
component interventions, particularly one to one discus-
sions with a skilled facilitator over a period of time, are
the most effective [9-14]. However, even with such
interventions, ADs may not be adequately disseminated
to influence patient care and health service use [12]. In
dementia care, guidance stipulates that such care plan-
ning discussions should take place whilst the person still
has capacity to make decisions [15]. The number of
ADs made by people with dementia has traditionally
been lower than for people with cancer [16]. In terms of
the impact of ACP on dementia care, a reduction in
unnecessary hospital admissions after ADs has been
shown [17,18]. A Cochrane review is currently underway
to assess the effects of interventions to promote the use
of ADs in end of life decision-making in all adults [19].
However there is a lack of evidence on the effectiveness
ACP in areas where loss of capacity will undoubtedly
occur such as in dementia and also a lack of under-
standing as to why people with dementia are less likely
than those with cancer to complete an AD. Advance
care planning may be particularly relevant in conditions
such as dementia, where patients are likely to experience
an extended period of mental incapacity but may still be
in relatively good physical health, so that ACP may need
to consider aspects of care beyond the end-of-life deci-
sions that are the focus of most advance directives.
In the United Kingdom (UK), the End of Life Care
Strategy was introduced to ensure that people’si n d i v i -
dual needs, priorities and preferences for end of life care
were identified, documented, reviewed, respected and
acted upon wherever possible [20]. Although guidance
on ACP is available for both professionals and patients
[1,21,22], the process does not yet appear to be
embedded into routine practice [23] and factors which
facilitate the process need to be defined. Research is
urgently needed to address both the knowledge transfer
gap to facilitate the integration of ACP into routine clin-
ical practice and to establish whether ADs, if implemen-
ted, influence patient care and choice [12,23,24].
This paper describes the protocol of a multidisciplin-
ary study that will provide timely and essential insights
into an area of end of life care, ACP, which has become
policy driven in the UK despite a weak evidence base.
The project will particularly focus on ACP in dementia
where people are highly likely to experience prolonged
periods of mental incapacity during which it will be
important for health professionals to know an indivi-
dual’s preferences for care. However it will also deter-
mine the factors that, in general, facilitate or hinder
people taking part in such potentially sensitive discus-
sions, in order to provide a better understanding of how
the process of ACP can become better integrated into
the routine care of people with long term conditions
and in particular those living with dementia.
Methods/Design
The aim of this study is to explore how the process of
ACP can become implemented in the routine care of
people with long term conditions, and in particular
dementia, where loss of capacity will inevitably occur
and where communication and memory difficulties may
make such ACP discussions more challenging. The
study will provide a better understanding of the views
and experiences of all relevant stakeholders, including
patients, family carers and professionals, in order to
inform clinical practice. Specifically it will:
1. Define the factors which facilitate and inhibit the
process of ACP in practice;
2. Explore how ACP can be implemented in poten-
tially more challenging situ a t i o n ss u c ha si nd e m e n t i a
care;
3. Critically appraise and synthesise existing evidence
on the effectiveness of ACP in dementia;
4. Identify the professional competencies and training
required to implement ACP;
5. Develop practical guidance for professionals,
patients and carers on ACP with a focus on dementia
care.
The project comprises a systematic review and a series
of qualitative studies, with data collection via focus
groups and individual interviews. Focus groups will be
employed to seek the perspectives of health and social
care professionals, supplemented with interviews to
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in the focus groups. Focus groups enable the researcher
to capitalise on communication and critical discussion
between research participants in order to generate data;
it is often recommended that focus groups be homoge-
nous but the advantages of including a more diverse
group are also recognised (i.e. a range of professions).
Individual interviews will be used to explore the per-
spectives of people living with a long term condition
such as those with dementia, and their family carers on
ACP. Focused interviews are a particularly useful tool to
employ in an area where little is known, they are also
flexible enough to allow the interviewer and interviewee
to explore potentially sensitive and challenging issues
which are pertinent to the individual.
Phase 1: Existing evidence on the effectiveness and
feasibility of ACP
The aims of Phase 1 are:
￿ To determine the factors which influence the imple-
mentation of ACP, to allow us to learn from and build
upon experiences of ACP in other populations and
settings.
￿ To assess the effectiveness and acceptability of ACP
in one specific long term illness, dementia.
Methods
In order to refine the scope of our review and identify
existing reviews, preliminary pilot searches were carried
out. Key databases were searched including but not lim-
ited to Medline, Embase, Cinahl, the Cochrane Database
of Systematic Reviews (CDSR) and Sociological
Abstracts. This identified a number of systematic
reviews which focused on the effectiveness of interven-
tions to promote the use of ACP in a variety of health
care settings [9-14]. These reviews included almost
exclusively quantitative sources of evidence about ACP.
In addition, most focused on the effectiveness of differ-
ent types of intervention to facilitate the completion of
ADs; there were few which explored the effectiveness of
ADs on influencing patient outcomes, such as preferred
place of care, and health resource use e.g. unplanned
hospital admissions [10,12].
Also identified was a recent protocol registered with
the Cochrane Collaboration on Interventions for promot-
ing the use of advance directives for end of life decisions
in adults [19]. This systematic review will appraise and
synthesise evidence on AD research in populations
including all adults aged over 18 with no restrictions on
their health status. On completion of the pilot searches
we concluded that a systematic review focused specifi-
cally on the effectiveness of ACP in an area of long
term care where loss of capacity was inevitable, and
where such discussions may be more challenging as in
dementia, is warranted. The conduct of the systematic
review in terms of identifying and synthesising relevant
quantitative data will follow current best practice gui-
dance [25].
Phase 2: Health professionals’ experiences of ACP in
practice
The aims of Phase 2 are:
￿ To explore health professionals’ views and experi-
ences of carrying out ACP.
￿ To determine the factors which facilitate or inhibit
the implementation of ACP.
￿ To identify the professional competencies essential
for carrying out ACP in practice.
Sampling
The sample (up to 60) will include health care profes-
sionals from one Primary Care Trust (PCT) in the UK.
As part of the NHS End of Life Programme, Newcastle
upon Tyne PCT Specialist Palliative Care Team has
developed training on ACP and identified documenta-
tion for staff to use from a review of existing documents
[20]. The ACP process is facilitated by healthcare pro-
fessionals, who have received the appropriate training
and is for any patient defined as having a life-limiting
illness and at risk of dying within 1 year; within primary
care, these will be mainly patients on the practice pallia-
tive care register. Training was introduced in 2007 and
to date, 85 health care professionals from the trust have
received the training. A purposive sample of health care
professionals will be selected to reflect:
i) a range of clinical perspectives including General
Practitioners (GPs), community nurses and multidisci-
plinary members of community rehabilitation teams and
ii) a range of experience of ACP, i.e. those who have
received training, those who have indicated a desire to
undertake the training but not yet received it, and those
who have been offered ACP training but declined to
participate.
Methods
Focus groups (up to 6), and individual interviews (up to
20) for those unable to attend the focus group, will be
conducted. Where possible, the focus groups will
include participants of similar experience and profes-
sional background. The focus groups/interviews will
explore:- participant views and experiences of carrying
out ACP in practice, including both the process and
documentation; the factors that promote or inhibit ACP
in clinical practice; the skills and competencies required
to carry out ACP successfully and whether any extra
training or resources are needed, and any areas where
they feel ACP is more difficult to carry out in practice.
Potential participants will be initially contacted by New-
castle upon Tyne PCT Community Palliative Care Team
to inform them about the study; those expressing inter-
est in the study will be sent a letter from the project
team and a study information sheet. Potential partici-
pants will have up to 1 week to decide if they wish to
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data collection.
Phase 3: ACP in dementia care
Aim
The aims of phase 3 are
￿ To explore the views and experiences of key stake-
holders (people with dementia, their carers and relevant
professionals) on the process and timing of ACP in
dementia care.
￿ To determine the factors which facilitate or inhibit
the implementation of ACP in dementia care.
￿ To identify the professional competencies essential
for carrying out ACP in dementia care.
Sample
Up to twenty people with mild dementia (Mini Mental
State Examination score ≥21) and their main lay carer
(up to 20); a purposive sample will be sought to ensure
maximum variation of age, type of carer and living
situation. Potential participants will be identified
through Old Age Psychiatry Services in 2 secondary
care trusts. People with dementia will initially be con-
tacted by a professional known to them to ascertain if
they are willing to be approached about the study. If
they are, a letter and study information sheet will be
sent from the project team. They will have 1 week to
decide if they wish to take part. Written consent would
be secured prior to the interview beginning; if this were
not possible then verbal consent would be recorded.
Patients would be reassured that declining to participate,
or subsequently withdrawing from participation, would
not affect their care.
Sampling in this phase will also include representa-
tives from the following professional groups: general
practitioners (GPs), community nurses, old age psychia-
trists, community psychiatric nurses (CPNs), specialists
in the care of younger people with dementia, psycholo-
gists, social care professionals, legal professionals and
advocacy groups e.g. Alzheimer’sS o c i e t y .H e a l t hc a r e
professionals will be recruited from the participating
trusts; social care professionals will be recruited from
Social Services and advocacy representatives from advo-
cacy groups (e.g. Alzheimer’s Society; Age Concern)
within the study area. Legal representatives will be iden-
tified from either advocacy groups or university depart-
ments of law (Newcastle/Northumbria). A letter and
study information sheet would be sent from the project
team. Potential participants will have 1 week to decide if
they wish to become involved. Written consent would
be secured prior to data collection.
Methods
Interviews will be used to gather the views of people
with dementia and their carers. Specifically, we shall
enquire about their views on ACP discussions, how they
feel about taking part in such discussions, who they
might involve, which aspects of ACP they feel are most
important, and their views on the timing of ACP and
current ACP documents in use (such as the form used
by participating professionals in WP2 and examples
identified from WP1). We would also ask whether they
have any ACP plans in place already.
Focus groups will be used to gather data from the
professionals. We will explore participant views and
experiences of carrying out ACP in dementia care in
practice, including both the process, timing and docu-
mentation used; the factors that promote or inhibit
ACP; the skills and competencies required to carry out
ACP successfully and whether any extra training or
resources are needed and which professionals are best
placed to discuss and document ACP in dementia care.
Data preparation and analysis for Phases 2 and 3
All focus groups and interviews will be digitally
recorded and transcribed verbatim. In line with Data
Protection Legislation and Research Governance, all
information pertaining to individuals would be anon-
ymised. Following the principles of the ‘constant com-
parative method’ [26], data collection and analysis will
occur concurrently to allow for issues from earlier inter-
views to be explored in more depth in subsequent inter-
views. Thematic analysis will be conducted on the
transcripts. The validity of data interpretation will be
ensured by independent coding and cross-checking by
at least two members of the research team. The software
package NVivo will be used to facilitate data manage-
ment. Regular data analysis meetings will be held
throughout the data collection and analysis period by
the project team which includes representatives from
primary and secondary care, social science, social work
and psychology.
Phase 4: ACP in health care: guidance for best practice
The aims of phase 4 are:
￿ To develop guidance for patients, carers and health
and social care professionals on how best to implement
ACP in practice.
￿ To create educational tools for health and social care
professionals to enable the facilitation of timely and sen-
sitive ACP discussions with people with long term con-
ditions and in particular those living with dementia.
The project team will synthesise data from Phases 1, 2
and 3 in a series of team workshops to develop draft
guidance and educational tools for implementing ACP
in practice. The guidance will also identify who is best
placed to facilitate this process and the skills and com-
petencies required. We will also seek the opinions of
our study participants, including legal, health and social
care professionals and people with dementia and their
carers, on our initial draft guidance. Two task groups
will be held (up to 8 people in each) with participants
from phase 3, comprising i) legal, health and social care
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carers. The proposed guidance and educational tools
will also be presented to the project external advisory
group for feedback. Following analysis of data from
these groups, the guidance and tools will be refined by
the project team before further dissemation.
Ethical approval
This study has approval from Newcastle and North Tyne-
side 1 Research Committee (09/H0906/5) and research
governance approval from each participating trust site.
Members of the project team in direct contact with
patients have been issued with NHS honorary contracts.
Discussion
Following our initial pilot searches, we identified a sig-
nificant number of recent systematic reviews, albeit lar-
gely US-based, which mainly synthesised quantitative
data on the effectiveness of different interventions to
influence ACP outcomes. These reviews largely included
evidence from North America and reflected a particular
setting where legislation i.e. the Patient Self Determina-
tion Act, has influenced ACP; such findings may not be
relevant to other countries. Although we also discovered
a large number of qualitative studies on aspects of ACP
in a variety of health care settings, a review or synthesis
of this evidence does not appear to have been underta-
ken. Such a synthesis of the wider qualitative research
literature on ACP in all health care settings, in order to
identify the factors which influence implementation of
ACP discussions in any setting, may be a useful addition
to existing evidence. However there is currently a lack
of consensus as to how best to undertake a systematic
review of qualitative literature, although guidance on the
process of searching for qualitative evidence [27,28] and
approaches to qualitative data synthesis in a systematic
review are available [29-34].
Prior to the start of this study, there was very little
published UK research on the effectiveness of ACP,
despite its introduction into NHS policy on End of life
Care, although research is beginning to emerge [23].
This study was designed to address gaps in the literature
firstly by evaluating both the effectiveness and feasibility
of ACP in one particular area of long term care, demen-
tia where loss of capacity is inevitable, but also through
exploring in greater depth how ACP can best be carried
out in routine practice. This study affords the opportu-
nity to develop both a theoretical and practical under-
standing of an area which both patients and
professionals may find emotionally challenging to under-
take. Importantly, the study will also develop practical
tools, which are grounded in practice, for all relevant
stakeholders to enable the facilitation of timely and sen-
sitive ACP discussions.
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